InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.20
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
60,645.92
(
0.55%
)
Post# of 113993
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

RNsidersbuying

Send PM Follow Ignore
Followers 46
Posts 4492
Boards Moderated 0
Alias Born 07/26/2010

RNsidersbuying

Re: researcher59 post# 75849

Friday, 08/14/2020 9:15:09 AM

Friday, August 14, 2020 9:15:09 AM

Post# of 113993
IGC 2.20 (premarket) - they've managed to keep the Balance Sheet clean with no debt and approx. .60-cash. And the sky-high option premiums definitely deserve a further look...but...this one looks over flakey i.e.

Business Wire August 11, 2020...announced today that on July 30, 2020, the U.S. Food and Drug Administration (FDA) notified IGC that it has authorized the Company to initiate a Phase 1 human trial study

https://finance.yahoo.com/news/fda-approves-initiation-igc-cannabinoid-210300208.html

What would seem to be super positive news and they wait 12 full days to announce it, hmmmmmm
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up